Compare Orchid Pharma with IND SWIFT LA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs IND SWIFT LA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA IND SWIFT LA ORCHID PHARMA/
IND SWIFT LA
 
P/E (TTM) x -16.5 17.8 - View Chart
P/BV x 2.4 0.8 320.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA   IND SWIFT LA
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-21
IND SWIFT LA
Mar-21
ORCHID PHARMA/
IND SWIFT LA
5-Yr Chart
Click to enlarge
High Rs2,46590 2,726.9%   
Low Rs1820 91.1%   
Sales per share (Unadj.) Rs110.3150.8 73.1%  
Earnings per share (Unadj.) Rs-28.5-0.5 5,360.2%  
Cash flow per share (Unadj.) Rs-1.914.2 -13.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs159.9102.1 156.6%  
Shares outstanding (eoy) m40.8259.09 69.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.30.4 3,084.2%   
Avg P/E ratio x-43.5-103.4 42.1%  
P/CF ratio (eoy) x-665.63.9 -17,210.9%  
Price / Book Value ratio x7.80.5 1,439.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m50,6773,254 1,557.3%   
No. of employees `000NANA-   
Total wages/salary Rs m671979 68.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,5018,913 50.5%  
Other income Rs m152227 67.1%   
Total revenues Rs m4,6539,140 50.9%   
Gross profit Rs m2941,828 16.1%  
Depreciation Rs m1,089873 124.8%   
Interest Rs m5221,002 52.1%   
Profit before tax Rs m-1,165180 -647.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0212 0.0%   
Profit after tax Rs m-1,165-31 3,702.9%  
Gross profit margin %6.520.5 31.8%  
Effective tax rate %0117.5 0.0%   
Net profit margin %-25.9-0.4 7,333.1%  
BALANCE SHEET DATA
Current assets Rs m5,4999,442 58.2%   
Current liabilities Rs m1,4213,145 45.2%   
Net working cap to sales %90.670.6 128.3%  
Current ratio x3.93.0 128.9%  
Inventory Days Days2017 116.7%  
Debtors Days Days1,1011,771 62.2%  
Net fixed assets Rs m6,8748,139 84.5%   
Share capital Rs m408598 68.2%   
"Free" reserves Rs m6,1215,437 112.6%   
Net worth Rs m6,5296,035 108.2%   
Long term debt Rs m4,2758,841 48.4%   
Total assets Rs m12,37317,581 70.4%  
Interest coverage x-1.21.2 -104.4%   
Debt to equity ratio x0.71.5 44.7%  
Sales to assets ratio x0.40.5 71.7%   
Return on assets %-5.25.5 -94.2%  
Return on equity %-17.8-0.5 3,422.5%  
Return on capital %-6.07.9 -74.9%  
Exports to sales %88.171.5 123.2%   
Imports to sales %37.30-   
Exports (fob) Rs m3,9666,377 62.2%   
Imports (cif) Rs m1,677NA-   
Fx inflow Rs m3,9666,377 62.2%   
Fx outflow Rs m1,729116 1,491.7%   
Net fx Rs m2,2376,261 35.7%   
CASH FLOW
From Operations Rs m2361,349 17.5%  
From Investments Rs m672-102 -660.7%  
From Financial Activity Rs m-1,650-1,237 133.3%  
Net Cashflow Rs m-74210 -7,288.6%  

Share Holding

Indian Promoters % 90.0 42.0 214.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.2 19.7 26.2%  
FIIs % 1.8 0.2 809.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.0 58.0 17.2%  
Shareholders   33,533 24,528 136.7%  
Pledged promoter(s) holding % 32.7 86.9 37.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Jan 28, 2022 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA 5-YR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS